More than 1.3 million U. S. construction workers are exposed to asbestos each year. It is estimated that there will be about 250,000 cases of malignant Mesothelioma before 2020.

Over 27 million people in the U. S. are at risk of developing malignant Mesothelioma from asbestos exposure. Asbestos manufactures knew of the long term dangers of asbestos exposure but chose to ignore or downplay the role asbestos played in many reported illnesses.

More than 10,000 Americans in the U. S. will be diagnosed with Mesothelioma and other asbestos-related diseases each year. Malignant Mesothelioma is a rare cancer that affects the lining of the lungs, abdomen, heart and major organs of the body.

The number of people diagnosed with asbestos caused diseases in the U.S. continues to increase. Experts believe 60,000 mesothelioma deaths will occur between 2010 and 2030. The 3 main treatments for Mesothelioma are: surgery, radiation and chemotherapy.

Malignant Mesothelioma is caused by exposure to asbestos through ingestion or inhaling of microscopic asbestos fibers as small .3 microns. Mesothelioma symptoms may not appear for 10-40 years after first exposure.

The Law Offices of Jerry Neil Paul has produced some of the most notable verdicts and highest settlements in the United States. Over 500 of our clients have each obtained in excess of 1 million dollars. Over 250 have recovered multi-million dollar recoveries.

EIGHTH ANNUAL GOLF INVITATIONAL BENEFITING THE MESOTHELIOMA RESEARCH FOUNDATION OF AMERICA

Tuesday, July 27, 2010

Law Offices of Jerry Neil Paul was the title sponsor for the Eighth Annual Golf Invitational Benefiting the Mesothelioma Research Foundation of America.  The event, which was held on July 26, 2010, was organized by Southern California Pipe Trades District Council 16.

The Mesothelioma Research Foundation of America was created to fund research dedicated to the cure of mesothelioma.  As part of its work, the Foundation has funded the Mesothelioma Laboratory at USC Norris, which has since received approval for clinical trials of the mesothelioma treatment drug, Veglin

John Ferruccio, DC 16 Organizer; Jerry Neil Paul, Partner of Law Offices of Jerry Neil Paul;Jim Kellogg; International UA Representative; Dr. Parkash Gill, USC Norris Oncologist